Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Tat
Milatuzumab-Sn-38 Conjugates for the Treatment of CD74+ Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-Sn-38 Antibody-Drug Conjugate for the Treatment of Diverse Epithelial Cancers: Safety and Pharmacokinetics
Cancer
Cancer Research
Oncology
Functional-Segregated Coumarin-Containing Telodendrimer Nanocarriers for Efficient Delivery of SN-38 for Colon Cancer Treatment
Acta Biomaterialia
Molecular Biology
Biochemistry
Biomaterials
Medicine
Biotechnology
Biomedical Engineering
Development of Anti-Cd74 AntibodyDrug Conjugates to Target Glucocorticoids to Immune Cells
Effect of 5-Fluorouracil Treatment on SN-38 Absorption From Intestine in Rats
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Nanoparticles for the Treatment of Lung Cancers
Journal of Young Pharmacists
Toxicology
Pharmaceutics
Pharmacology
Nanoparticle-Mediated Delivery of a Rapidly Activatable Prodrug of SN-38 for Neuroblastoma Therapy
Biomaterials
Mechanics of Materials
Biophysics
Biomaterials
Bioengineering
Composites
Nanoscience
Nanotechnology
Ceramics
A Phase I-Ii Clinical Trial of the Anti-Cd74 Monoclonal Antibody Milatuzumab in Frail Patients With Refractory Chronic Lymphocytic Leukaemia: A Patient Based Approach
British Journal of Haematology
Hematology
Determination of Irinotecan, SN-38 and SN-38 Glucuronide Using HPLC/MS/MS: Application in a Clinical Pharmacokinetic and Personalized Medicine in Colorectal Cancer Patients
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
The UGT1A1∗28 Polymorphism Correlates With Erlotinib’s Effect on SN-38 Glucuronidation
European Journal of Cancer
Cancer Research
Oncology
